Hunan Er Kang Pharmaceutical Net Asset Momentum
Hunan Er Kang Pharmaceutical net asset momentum. Hunan Er Kang Pharmaceutical (300267) recorded a net asset momentum of -8.5% as of December 2024, with net assets of CN¥4.40 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore how much does Hunan Er Kang Pharmaceutical reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Hunan Er Kang Pharmaceutical (2008–2024)
Net asset momentum of Hunan Er Kang Pharmaceutical from 2008 to 2024. This chart tracks Hunan Er Kang Pharmaceutical's year-over-year net asset growth across 17 annual reporting periods from 2008 to 2024. The most recent momentum reading is -8.5%, with net assets of CN¥4.40 Billion CNY as of December 2024. See Hunan Er Kang Pharmaceutical net assets for net asset value and shareholders' equity analysis.
Hunan Er Kang Pharmaceutical Net Asset Momentum by Year (2008–2024)
Hunan Er Kang Pharmaceutical net asset momentum by year from 2008 to 2024. The table below shows the complete annual net asset history for Hunan Er Kang Pharmaceutical from 2008 to 2024, covering 17 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Hunan Er Kang Pharmaceutical market cap and net worth.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥4.40 Billion | CN¥5.20 Billion | CN¥797.54 Million | ▼ -8.5% |
| 2023 | CN¥4.81 Billion | CN¥5.48 Billion | CN¥669.05 Million | ▼ -4.8% |
| 2022 | CN¥5.05 Billion | CN¥5.86 Billion | CN¥804.57 Million | ▲ +3.6% |
| 2021 | CN¥4.87 Billion | CN¥5.43 Billion | CN¥558.28 Million | ▼ -15.9% |
| 2020 | CN¥5.79 Billion | CN¥6.55 Billion | CN¥753.22 Million | ▲ +0.0% |
| 2019 | CN¥5.79 Billion | CN¥6.14 Billion | CN¥350.72 Million | ▲ +2.7% |
| 2018 | CN¥5.64 Billion | CN¥6.05 Billion | CN¥409.39 Million | ▲ +4.2% |
| 2017 | CN¥5.41 Billion | CN¥5.72 Billion | CN¥308.37 Million | ▲ +3.2% |
| 2016 | CN¥5.24 Billion | CN¥5.65 Billion | CN¥408.94 Million | ▲ +23.2% |
| 2015 | CN¥4.26 Billion | CN¥4.80 Billion | CN¥544.10 Million | ▲ +153.7% |
| 2014 | CN¥1.68 Billion | CN¥2.22 Billion | CN¥542.64 Million | ▲ +25.8% |
| 2013 | CN¥1.33 Billion | CN¥1.45 Billion | CN¥113.01 Million | ▲ +14.6% |
| 2012 | CN¥1.16 Billion | CN¥1.24 Billion | CN¥73.32 Million | ▲ +9.6% |
| 2011 | CN¥1.06 Billion | CN¥1.13 Billion | CN¥65.90 Million | ▲ +501.4% |
| 2010 | CN¥176.62 Million | CN¥295.77 Million | CN¥119.15 Million | ▲ +60.6% |
| 2009 | CN¥110.01 Million | CN¥185.73 Million | CN¥75.72 Million | ▲ +74.6% |
| 2008 | CN¥63.01 Million | CN¥122.38 Million | CN¥59.37 Million | — |